| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. | President and CEO, Director | Common Shares | 303,721 | $683,372 | $2.25 | 08 Jan 2026 | Direct |
| Milestone Pharmaceuticals Inc. | President and CEO, Director | Employee Stock Option (right to buy) | 399,600 | 27 Jan 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | President and CEO, Director | Restricted Stock Unit | 266,400 | 27 Jan 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | President and CEO, Director | Series A Common Warrants (right to buy) | 66,666 | 11 Jul 2025 | Direct | ||
| Milestone Pharmaceuticals Inc. | President and CEO, Director | Series B Common Warrants (right to buy) | 66,666 | 11 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MIST | Milestone Pharmaceuticals Inc. | 07 Jan 2026 | 2 | -$97,875 | 4 | President and CEO, Director | 09 Jan 2026, 16:53 |
| MIST | Milestone Pharmaceuticals Inc. | 11 Jul 2025 | 3 | $0 | 4 | President and CEO, Director | 15 Jul 2025, 16:15 |
| MIST | Milestone Pharmaceuticals Inc. | 27 Jan 2025 | 2 | $0 | 4 | President and CEO, Director | 29 Jan 2025, 16:15 |
| MIST | Milestone Pharmaceuticals Inc. | 16 Feb 2023 | 1 | $0 | 4 | President and CEO, Director | 17 Feb 2023, 15:49 |
| MIST | Milestone Pharmaceuticals Inc. | 21 Mar 2022 | 1 | $0 | 4 | President and CEO, Director | 23 Mar 2022, 21:47 |